APO Research
Talk to an analyst

APO RESEARCH · REPORT

cfDNA Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global cfDNA Testing Market Analysis and Forecast 2026-2032

8 January 2026193 pages

Choose your research edition.

Industry ResearchcfDNA Testing Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal cfDNA Testing Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal cfDNA Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal cfDNA Testing Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal cfDNA Testing Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global cfDNA Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for cfDNA Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for cfDNA Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for cfDNA Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for cfDNA Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of cfDNA Testing include Illumina, Oncogenomics, Revvity, CareDx, Natera, BillionToOne, Inc., Yourgene Health, ARUP Laboratories and Roche, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for cfDNA Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of cfDNA Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for cfDNA Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the cfDNA Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global cfDNA Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for cfDNA Testing revenue, projected growth trends, production technology, application and end-user industry.

cfDNA Testing Segment by Company

Illumina

Oncogenomics

Revvity

CareDx

Natera

BillionToOne, Inc.

Yourgene Health

ARUP Laboratories

Roche

cfDNA Testing Segment by Type

Targeted Sequencing

Whole Genome Sequencing

cfDNA Testing Segment by Application

Prenatal Testing

Oncology

Organ Transplant Monitoring

Others

cfDNA Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global cfDNA Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of cfDNA Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of cfDNA Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of cfDNA Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of cfDNA Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, cfDNA Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global cfDNA Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Targeted Sequencing Major Player Table 3. Whole Genome Sequencing Major Player Table 4. Global cfDNA Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Prenatal Testing Major Player Table 6. Oncology Major Player Table 7. Organ Transplant Monitoring Major Player Table 8. Others Major Player Table 9. cfDNA Testing Industry Trends Table 10. cfDNA Testing Industry Drivers Table 11. cfDNA Testing Industry Opportunities and Challenges Table 12. cfDNA Testing Industry Restraints Table 13. Global cfDNA Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global cfDNA Testing Market Size by Region (2021-2026) & (US$ Million) Table 15. Global cfDNA Testing Market Share by Region (2021-2026) Table 16. Global cfDNA Testing Market Size by Region (2027-2032) & (US$ Million) Table 17. Global cfDNA Testing Market Share by Region (2027-2032) Table 18. Global cfDNA Testing Revenue by Players (US$ Million) & (2021-2026) Table 19. Global cfDNA Testing Revenue Market Share by Players (2021-2026) Table 20. Global cfDNA Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global cfDNA Testing Key Players Headquarters & Area Served Table 22. Global cfDNA Testing Players, Product Type & Application Table 23. Global cfDNA Testing Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global cfDNA Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global cfDNA Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global cfDNA Testing Revenue by Type (2021-2026) & (US$ Million) Table 28. Global cfDNA Testing Revenue by Type (2027-2032) & (US$ Million) Table 29. Global cfDNA Testing Revenue Market Share by Type (2021-2026) Table 30. Global cfDNA Testing Revenue Market Share by Type (2027-2032) Table 31. Global cfDNA Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global cfDNA Testing Revenue by Application (2021-2026) & (US$ Million) Table 33. Global cfDNA Testing Revenue by Application (2027-2032) & (US$ Million) Table 34. Global cfDNA Testing Revenue Market Share by Application (2021-2026) Table 35. Global cfDNA Testing Revenue Market Share by Application (2027-2032) Table 36. Illumina Company Information Table 37. Illumina Business Overview Table 38. Illumina cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Illumina cfDNA Testing Product Portfolio Table 40. Illumina Recent Development Table 41. Oncogenomics Company Information Table 42. Oncogenomics Business Overview Table 43. Oncogenomics cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Oncogenomics cfDNA Testing Product Portfolio Table 45. Oncogenomics Recent Development Table 46. Revvity Company Information Table 47. Revvity Business Overview Table 48. Revvity cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Revvity cfDNA Testing Product Portfolio Table 50. Revvity Recent Development Table 51. CareDx Company Information Table 52. CareDx Business Overview Table 53. CareDx cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. CareDx cfDNA Testing Product Portfolio Table 55. CareDx Recent Development Table 56. Natera Company Information Table 57. Natera Business Overview Table 58. Natera cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Natera cfDNA Testing Product Portfolio Table 60. Natera Recent Development Table 61. BillionToOne, Inc. Company Information Table 62. BillionToOne, Inc. Business Overview Table 63. BillionToOne, Inc. cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. BillionToOne, Inc. cfDNA Testing Product Portfolio Table 65. BillionToOne, Inc. Recent Development Table 66. Yourgene Health Company Information Table 67. Yourgene Health Business Overview Table 68. Yourgene Health cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Yourgene Health cfDNA Testing Product Portfolio Table 70. Yourgene Health Recent Development Table 71. ARUP Laboratories Company Information Table 72. ARUP Laboratories Business Overview Table 73. ARUP Laboratories cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. ARUP Laboratories cfDNA Testing Product Portfolio Table 75. ARUP Laboratories Recent Development Table 76. Roche Company Information Table 77. Roche Business Overview Table 78. Roche cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Roche cfDNA Testing Product Portfolio Table 80. Roche Recent Development Table 81. North America cfDNA Testing Revenue by Type (2021-2026) & (US$ Million) Table 82. North America cfDNA Testing Revenue by Type (2027-2032) & (US$ Million) Table 83. North America cfDNA Testing Revenue by Application (2021-2026) & (US$ Million) Table 84. North America cfDNA Testing Revenue by Application (2027-2032) & (US$ Million) Table 85. North America cfDNA Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 86. North America cfDNA Testing Revenue by Country (2021-2026) & (US$ Million) Table 87. North America cfDNA Testing Revenue by Country (US$ Million) & (2027-2032) Table 88. Europe cfDNA Testing Revenue by Type (2021-2026) & (US$ Million) Table 89. Europe cfDNA Testing Revenue by Type (2027-2032) & (US$ Million) Table 90. Europe cfDNA Testing Revenue by Application (2021-2026) & (US$ Million) Table 91. Europe cfDNA Testing Revenue by Application (2027-2032) & (US$ Million) Table 92. Europe cfDNA Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Europe cfDNA Testing Revenue by Country (2021-2026) & (US$ Million) Table 94. Europe cfDNA Testing Revenue by Country (US$ Million) & (2027-2032) Table 95. China cfDNA Testing Revenue by Type (2021-2026) & (US$ Million) Table 96. China cfDNA Testing Revenue by Type (2027-2032) & (US$ Million) Table 97. China cfDNA Testing Revenue by Application (2021-2026) & (US$ Million) Table 98. China cfDNA Testing Revenue by Application (2027-2032) & (US$ Million) Table 99. Asia cfDNA Testing Revenue by Type (2021-2026) & (US$ Million) Table 100. Asia cfDNA Testing Revenue by Type (2027-2032) & (US$ Million) Table 101. Asia cfDNA Testing Revenue by Application (2021-2026) & (US$ Million) Table 102. Asia cfDNA Testing Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia cfDNA Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Asia cfDNA Testing Revenue by Region (US$ Million) & (2021-2026) Table 105. Asia cfDNA Testing Revenue by Region (US$ Million) & (2027-2032) Table 106. SAMEA cfDNA Testing Revenue by Type (2021-2026) & (US$ Million) Table 107. SAMEA cfDNA Testing Revenue by Type (2027-2032) & (US$ Million) Table 108. SAMEA cfDNA Testing Revenue by Application (2021-2026) & (US$ Million) Table 109. SAMEA cfDNA Testing Revenue by Application (2027-2032) & (US$ Million) Table 110. SAMEA cfDNA Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. SAMEA cfDNA Testing Revenue by Country (2021-2026) & (US$ Million) Table 112. SAMEA cfDNA Testing Revenue by Country (US$ Million) & (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. cfDNA Testing Image Figure 2. Global cfDNA Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global cfDNA Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Targeted Sequencing Image Figure 5. Whole Genome Sequencing Image Figure 6. Global cfDNA Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global cfDNA Testing Market Size Share 2021 VS 2025 VS 2032 Figure 8. Prenatal Testing Image Figure 9. Oncology Image Figure 10. Organ Transplant Monitoring Image Figure 11. Others Image Figure 12. Global cfDNA Testing Market Size (US$ Million) & (2021-2032) Figure 13. Global cfDNA Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global cfDNA Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global cfDNA Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global cfDNA Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global cfDNA Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global cfDNA Testing Revenue Market Share by Type (2021-2032) Figure 20. Global cfDNA Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global cfDNA Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global cfDNA Testing Revenue Market Share by Application (2021-2032) Figure 23. North America cfDNA Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America cfDNA Testing Revenue Share by Type (2021-2032) Figure 25. North America cfDNA Testing Revenue Share by Application (2021-2032) Figure 26. North America cfDNA Testing Revenue Share by Country (2021-2032) Figure 27. United States cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe cfDNA Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe cfDNA Testing Revenue Share by Type (2021-2032) Figure 32. Europe cfDNA Testing Revenue Share by Application (2021-2032) Figure 33. Europe cfDNA Testing Revenue Share by Country (2021-2032) Figure 34. Germany cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China cfDNA Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China cfDNA Testing Revenue Share by Type (2021-2032) Figure 44. China cfDNA Testing Revenue Share by Application (2021-2032) Figure 45. Asia cfDNA Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia cfDNA Testing Revenue Share by Type (2021-2032) Figure 47. Asia cfDNA Testing Revenue Share by Application (2021-2032) Figure 48. Asia cfDNA Testing Revenue Share by Region (2021-2032) Figure 49. Japan cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA cfDNA Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA cfDNA Testing Revenue Share by Type (2021-2032) Figure 57. SAMEA cfDNA Testing Revenue Share by Application (2021-2032) Figure 58. SAMEA cfDNA Testing Revenue Share by Country (2021-2032) Figure 59. Brazil cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt cfDNA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Sequencing
  • Whole Genome Sequencing
Applications
  • Prenatal Testing
  • Oncology
  • Organ Transplant Monitoring
  • Others
Companies covered
  • Illumina
  • Oncogenomics
  • Revvity
  • CareDx
  • Natera
  • BillionToOne, Inc.
  • Yourgene Health
  • ARUP Laboratories
  • Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 cfDNA Testing Market by Type
  3. 1.2.1 Global cfDNA Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Targeted Sequencing
  5. 1.2.3 Whole Genome Sequencing
  6. 1.3 cfDNA Testing Market by Application
  7. 1.3.1 Global cfDNA Testing Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Prenatal Testing
  9. 1.3.3 Oncology
  10. 1.3.4 Organ Transplant Monitoring
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 cfDNA Testing Market Dynamics
  1. 2.1 cfDNA Testing Industry Trends
  2. 2.2 cfDNA Testing Industry Drivers
  3. 2.3 cfDNA Testing Industry Opportunities and Challenges
  4. 2.4 cfDNA Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global cfDNA Testing Market Perspective (2021-2032)
  2. 3.2 Global cfDNA Testing Growth Trends by Region
  3. 3.2.1 Global cfDNA Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global cfDNA Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global cfDNA Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global cfDNA Testing Revenue by Players
  2. 4.1.1 Global cfDNA Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global cfDNA Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global cfDNA Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global cfDNA Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global cfDNA Testing Key Players Headquarters & Area Served
  7. 4.4 Global cfDNA Testing Players, Product Type & Application
  8. 4.5 Global cfDNA Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global cfDNA Testing Market CR5 and HHI
  11. 4.6.3 2025 cfDNA Testing Tier 1, Tier 2, and Tier 3
5 cfDNA Testing Market Size by Type
  1. 5.1 Global cfDNA Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global cfDNA Testing Revenue by Type (2021-2032)
  3. 5.3 Global cfDNA Testing Revenue Market Share by Type (2021-2032)
6 cfDNA Testing Market Size by Application
  1. 6.1 Global cfDNA Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global cfDNA Testing Revenue by Application (2021-2032)
  3. 6.3 Global cfDNA Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Illumina
  2. 7.1.1 Illumina Company Information
  3. 7.1.2 Illumina Business Overview
  4. 7.1.3 Illumina cfDNA Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Illumina cfDNA Testing Product Portfolio
  6. 7.1.5 Illumina Recent Developments
  7. 7.2 Oncogenomics
  8. 7.2.1 Oncogenomics Company Information
  9. 7.2.2 Oncogenomics Business Overview
  10. 7.2.3 Oncogenomics cfDNA Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Oncogenomics cfDNA Testing Product Portfolio
  12. 7.2.5 Oncogenomics Recent Developments
  13. 7.3 Revvity
  14. 7.3.1 Revvity Company Information
  15. 7.3.2 Revvity Business Overview
  16. 7.3.3 Revvity cfDNA Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Revvity cfDNA Testing Product Portfolio
  18. 7.3.5 Revvity Recent Developments
  19. 7.4 CareDx
  20. 7.4.1 CareDx Company Information
  21. 7.4.2 CareDx Business Overview
  22. 7.4.3 CareDx cfDNA Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 CareDx cfDNA Testing Product Portfolio
  24. 7.4.5 CareDx Recent Developments
  25. 7.5 Natera
  26. 7.5.1 Natera Company Information
  27. 7.5.2 Natera Business Overview
  28. 7.5.3 Natera cfDNA Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Natera cfDNA Testing Product Portfolio
  30. 7.5.5 Natera Recent Developments
  31. 7.6 BillionToOne, Inc.
  32. 7.6.1 BillionToOne, Inc. Company Information
  33. 7.6.2 BillionToOne, Inc. Business Overview
  34. 7.6.3 BillionToOne, Inc. cfDNA Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 BillionToOne, Inc. cfDNA Testing Product Portfolio
  36. 7.6.5 BillionToOne, Inc. Recent Developments
  37. 7.7 Yourgene Health
  38. 7.7.1 Yourgene Health Company Information
  39. 7.7.2 Yourgene Health Business Overview
  40. 7.7.3 Yourgene Health cfDNA Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Yourgene Health cfDNA Testing Product Portfolio
  42. 7.7.5 Yourgene Health Recent Developments
  43. 7.8 ARUP Laboratories
  44. 7.8.1 ARUP Laboratories Company Information
  45. 7.8.2 ARUP Laboratories Business Overview
  46. 7.8.3 ARUP Laboratories cfDNA Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 ARUP Laboratories cfDNA Testing Product Portfolio
  48. 7.8.5 ARUP Laboratories Recent Developments
  49. 7.9 Roche
  50. 7.9.1 Roche Company Information
  51. 7.9.2 Roche Business Overview
  52. 7.9.3 Roche cfDNA Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Roche cfDNA Testing Product Portfolio
  54. 7.9.5 Roche Recent Developments
8 North America
  1. 8.1 North America cfDNA Testing Revenue (2021-2032)
  2. 8.2 North America cfDNA Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America cfDNA Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America cfDNA Testing Revenue by Type (2027-2032)
  5. 8.3 North America cfDNA Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America cfDNA Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America cfDNA Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America cfDNA Testing Revenue by Application (2027-2032)
  9. 8.5 North America cfDNA Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America cfDNA Testing Revenue by Country
  11. 8.6.1 North America cfDNA Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America cfDNA Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America cfDNA Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe cfDNA Testing Revenue (2021-2032)
  2. 9.2 Europe cfDNA Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe cfDNA Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe cfDNA Testing Revenue by Type (2027-2032)
  5. 9.3 Europe cfDNA Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe cfDNA Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe cfDNA Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe cfDNA Testing Revenue by Application (2027-2032)
  9. 9.5 Europe cfDNA Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe cfDNA Testing Revenue by Country
  11. 9.6.1 Europe cfDNA Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe cfDNA Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe cfDNA Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China cfDNA Testing Revenue (2021-2032)
  2. 10.2 China cfDNA Testing Revenue by Type (2021-2032)
  3. 10.2.1 China cfDNA Testing Revenue by Type (2021-2026)
  4. 10.2.2 China cfDNA Testing Revenue by Type (2027-2032)
  5. 10.3 China cfDNA Testing Revenue Share by Type (2021-2032)
  6. 10.4 China cfDNA Testing Revenue by Application (2021-2032)
  7. 10.4.1 China cfDNA Testing Revenue by Application (2021-2026)
  8. 10.4.2 China cfDNA Testing Revenue by Application (2027-2032)
  9. 10.5 China cfDNA Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia cfDNA Testing Revenue (2021-2032)
  2. 11.2 Asia cfDNA Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia cfDNA Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia cfDNA Testing Revenue by Type (2027-2032)
  5. 11.3 Asia cfDNA Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia cfDNA Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia cfDNA Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia cfDNA Testing Revenue by Application (2027-2032)
  9. 11.5 Asia cfDNA Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia cfDNA Testing Revenue by Country
  11. 11.6.1 Asia cfDNA Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia cfDNA Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia cfDNA Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA cfDNA Testing Revenue (2021-2032)
  2. 12.2 SAMEA cfDNA Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA cfDNA Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA cfDNA Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA cfDNA Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA cfDNA Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA cfDNA Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA cfDNA Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA cfDNA Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA cfDNA Testing Revenue by Country
  11. 12.6.1 SAMEA cfDNA Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA cfDNA Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA cfDNA Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst